Free tool
Heavily traded stocks
We cover 47 companies whose typical session turns over more than $10.00M. The median market value in the group is $6.89B. Across the group, the median move over the past trading day is −0.99%. 52% of the 46 with a 200-day average trade above it. Price change over the past year runs from −27.0% to +54.2% across the middle 80 percent of the group, with a median of +4.9%.
Other lists in this group
Table
47 of 7,336 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| 4519.T | Chugai Pharmaceutical Co., Ltd. | $71.92B | Large cap | +9.21% |
| CSL.AX | CSL Limited | $59.72B | Large cap | −16.37% |
| 4502.T | Takeda Pharmaceutical Company Limited | $58.08B | Large cap | +36.03% |
| 207940.KS | Samsung Biologics Co.,Ltd. | $53.31B | Large cap | +2.12% |
| 7741.T | HOYA Corporation | $51.57B | Large cap | +28.99% |
| 4578.T | Otsuka Holdings Co., Ltd. | $40.39B | Large cap | +57.62% |
| RMD.AX | ResMed Inc. | $34.05B | Large cap | −24.75% |
| 4568.T | Daiichi Sankyo Company, Limited | $32.82B | Large cap | −17.94% |
| 068270.KS | Celltrion, Inc. | $31.91B | Large cap | +11.19% |
| 4503.T | Astellas Pharma Inc. | $26.88B | Large cap | +53.57% |
| 4543.T | Terumo Corporation | $23.67B | Large cap | −2.68% |
| SIG.AX | Sigma Healthcare Limited | $21.65B | Large cap | −15.21% |
| 4507.T | Shionogi & Co., Ltd. | $15.45B | Large cap | +15.63% |
| FPH.AX | Fisher & Paykel Healthcare Corporation Limited | $15.44B | Large cap | +11.27% |
| 7733.T | Olympus Corporation | $14.46B | Large cap | +27.06% |
| PME.AX | Pro Medicus Limited | $13.66B | Large cap | −39.15% |
| 4151.T | Kyowa Kirin Co., Ltd. | $8.51B | Mid cap | +4.01% |
| 4523.T | Eisai Co., Ltd. | $8.48B | Mid cap | +7.64% |
| RHC.AX | Ramsay Health Care Limited | $8.27B | Mid cap | +50.11% |
| 2413.T | M3, Inc. | $7.53B | Mid cap | −17.22% |
| 4528.T | Ono Pharmaceutical Co., Ltd. | $7.39B | Mid cap | +54.43% |
| 6869.T | Sysmex Corporation | $7.28B | Mid cap | +3.66% |
| SHL.AX | Sonic Healthcare Limited | $7.14B | Mid cap | −11.84% |
| 3391.T | Tsuruha Holdings Inc. | $6.89B | Mid cap | +5.97% |
| 0126Z0.KS | SAMSUNG EPIS HOLDINGS | $6.82B | Mid cap | +15.35% |
| 7747.T | Asahi Intecc Co., Ltd. | $6.68B | Mid cap | +53.99% |
| 3088.T | MatsukiyoCocokara & Co. | $6.45B | Mid cap | −14.74% |
| COH.AX | Cochlear Limited | $6.39B | Mid cap | −53.79% |
| 326030.KS | SK Biopharmaceuticals Co., Ltd. | $4.89B | Mid cap | −11.24% |
| 128940.KS | Hanmi Pharm. Co., Ltd. | $4.63B | Mid cap | +66.34% |
| 000100.KS | Yuhan Corporation | $4.50B | Mid cap | −27.54% |
| ANN.AX | Ansell Limited | $4.17B | Mid cap | +18.41% |
| 4506.T | Sumitomo Pharma Co., Ltd. | $4.05B | Mid cap | −3.59% |
| 000105.KS | Yuhan Corporation | $3.84B | Mid cap | −32.04% |
| TLX.AX | Telix Pharmaceuticals Limited | $3.82B | Mid cap | +4.88% |
| 4536.T | Santen Pharmaceutical Co., Ltd. | $3.74B | Mid cap | +21.45% |
| 7459.T | MediPal Holdings Corporation | $3.72B | Mid cap | +13.38% |
| 3349.T | COSMOS Pharmaceutical Corporation | $3.26B | Mid cap | −26.59% |
| 7649.T | Sugi Holdings Co.,Ltd. | $3.13B | Mid cap | −28.60% |
| 9989.T | Sundrug Co.,Ltd. | $2.76B | Mid cap | −17.34% |
| 2784.T | Alfresa Holdings Corporation | $2.53B | Mid cap | +6.80% |
| 3549.T | Kusuri No Aoki Holdings Co., Ltd. | $2.44B | Mid cap | +5.23% |
| 009420.KS | Hanall Biopharma Co., Ltd. | $2.36B | Mid cap | +112.62% |
| 302440.KS | SK bioscience Co.,Ltd. | $2.18B | Mid cap | −20.29% |
| 9987.T | Suzuken Co., Ltd. | $2.17B | Mid cap | −12.93% |
| 008930.KS | Hanmi Science Co., Ltd. | $2.11B | Mid cap | +2.80% |
| 6960.T | Fukuda Denshi Co., Ltd. | $2.02B | Mid cap | +79.12% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.